A Study of VCT220 in Participants With Hypertension and Obesity or Overweight

Study acronym: VICTOR-HTN
StatusActive, Not Recruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status changed: Not Yet Recruiting → Active, Not Recruiting Show 4 more changesShow less
    • Primary completion date: Oct 20, 2026 to Oct 30, 2026
    • Eligibility criteria expanded, about 22 words
    • Secondary endpoints: details revised at 2 of 6 entries
    • Site details revised at 2 of 2 sites
  2. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to explore the safety and efficacy of VCT220 for the treatment of hypertension in participants with obesity or overweight.
Trial Details
NCT Number NCT07360275
Lead Sponsor Vincentage Pharma Co., Ltd
Conditions
(from sponsor)		 Hypertension
Related terms Hypertension
Enrollment 160 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov